Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Topical ruxolitinib for the tr...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Topical ruxolitinib for the treatment of granuloma faciale

Topical ruxolitinib for the treatment of granuloma faciale

Bibliographic Details
Main Authors: Alan Wong, DO, Samuel Stahly, DO, Jason Kieffer, MD, Charles Dunn, MD, Rajiv Nathoo, MD
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:JAAD Case Reports
Subjects:
eosinophil-associated dermatosis
granuloma faciale
interferon-gamma
interleukin-5
JAK inhibitor
janus kinase
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512623001297
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2352512623001297

Similar Items

  • Ruxolitinib cream for the treatment of granuloma annulare
    by: Austin J. Piontkowski, BS, et al.
    Published: (2024-08-01)
  • Refractory granuloma faciale successfully treated with adjunct topical JAK inhibitor
    by: Ailynna Chen, MPH, et al.
    Published: (2023-03-01)
  • Successful treatment of recalcitrant follicular lichen planus (lichen planopilaris) with the topical JAK 1/2 inhibitor ruxolitinib
    by: Tanja Fetter, et al.
    Published: (2025-03-01)
  • Granuloma faciale as a diagnostic and therapeutic challenge
    by: Wiktor Leśniak, et al.
    Published: (2024-05-01)
  • Improvement of necrobiosis lipoidica with topical ruxolitinib cream after prior nonresponse to compounded topical tofacitinib cream
    by: Shannon Nugent, BS, et al.
    Published: (2022-11-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs